ORGANIZATION AND COLLABORATION Sample Clauses

ORGANIZATION AND COLLABORATION. 9.1 Office in the Commonwealth A. Enrollee Services; B. Provider Services, including Provider Relations, Network Development and Enrollment; C. Population Health Management staff D. Utilization Management Director E. Enrollee and Provider Complaint, Grievance, and Appeal Coordinator(s)
Sample 1Sample 2Sample 3See All (6)
AutoNDA by SimpleDocs
ORGANIZATION AND COLLABORATION. 9.1 Office in the Commonwealth A. Executive Director for the Kentucky account B. Member Services for Grievances and Appeals C. Provider Services for Provider Relations and Enrollment Other functions required to be available may be located outside of an eighty (80) mile radius of Frankfort, Kentucky. The Contractor may subcontract for any functions; however, the above functions, if subcontracted, shall be approved by the Department and shall be carried out within an eighty (80) mile radius of Frankfort, Kentucky within Kentucky. All Subcontractors shall meet appropriate licensing and contract requirements specified in applicable State and Federal laws and regulations.
Sample 1Sample 2Sample 3See All (4)
ORGANIZATION AND COLLABORATION. 9.1 Office in the Commonwealth A. Executive Team key personnel; B. Enrollee Services; C. Provider Services, including Provider Relations, Network Development and Enrollment; The Contractor shall also staff the following positions or equivalent to be located in and operate from within the State: A. Population Health Program Manager and staff B. Utilization Management Director X. Xxxxxxxx and Provider Complaint, Grievance, and Appeal Coordinator(s) X. XXXX Coordinator E. Program Integrity Coordinator The Contractor may opt to locate other functions outside of an eighty (80) mile radius of Frankfort, Kentucky, but shall locate such functions within the United States. The Contractor shall not provide services or functions under this Contract that are located outside of the United States. Additionally, no Claims paid by the Contractor to a Network Provider, Out-of-Network Provider, Subcontractor, or financial institution located outside of the United States shall be considered in the development of actuarially-sound Capitation Rates. The Contractor may Subcontract for any functions with Department approval as set forth in Section
Sample 1
ORGANIZATION AND COLLABORATION. The Contractor shall have an office located within eighty (80) miles of Frankfort, Kentucky within Kentucky within thirty (30) days of contract execution. Such office shall, at a minimum, provide for the following staff functions: A. Executive Director for the Kentucky account B. Member Services for Grievances and Appeals C. Provider Services for Provider Relations and Enrollment Other functions required to be available may be located outside of an eighty (80) mile radius of Frankfort, Kentucky. The Contractor may subcontract for any functions; however, the above functions, if subcontracted, shall be approved by the Department and shall be carried out within an eighty (80) mile radius of Frankfort, Kentucky.. All Subcontractors shall meet appropriate licensing and contract requirements specified in applicable State and Federal laws and regulations.
Sample 1

Related to ORGANIZATION AND COLLABORATION

  • Formation and Composition The Parties to this agreement will maintain a Joint Administration and Dispute Resolution Committee (JADRC) consisting of five (5) representatives of the employers and five (5) representatives of the Provincial Bargaining Council.

  • Incorporation and Organization The Corporation has been incorporated or formed, as the case may be, is organized and is a valid and subsisting corporation or partnership, as the case may be, under the laws of its jurisdiction of existence and has all requisite corporate power and capacity to carry on its business as now conducted or proposed to be conducted and to own or lease and operate the property and assets thereof.

  • Formation and Name Office; Purpose; Term

  • Organization and Status Purchaser (a) is duly formed, validly existing and in good standing under the laws of the jurisdiction of its formation as set forth in the preamble to this Agreement, (b) is duly qualified, authorized to do business and in good standing in each other jurisdiction where the character of its properties or the nature of its activities makes such qualification necessary, and (c) has all requisite power and authority to own or hold under lease the property it purports to own or hold under lease and to carry on its business as now being conducted. Purchaser has made available to Seller complete and correct copies of the Organization Documents for Purchaser.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Pricing Instrument; Execution and Incorporation of Terms The parties hereto will enter into this Indenture by executing the Pricing Instrument. By executing the Pricing Instrument, the Indenture Trustee, the Registrar, the Transfer Agent, the Paying Agent, the Calculation Agent and the Trust hereby agree that the Indenture will constitute a legal, valid and binding agreement between the Indenture Trustee, the Registrar, the Transfer Agent, the Paying Agent, the Calculation Agent and the Trust. All terms relating to the Trust or the Notes not otherwise included herein will be as specified in the Pricing Instrument or Pricing Supplement, as indicated herein.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Organization and Related Matters Buyer is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware.

  • Due Incorporation and Organization The Adviser is duly organized and is in good standing under the laws of the State of Connecticut and is fully authorized to enter into this Agreement and carry out its duties and obligations hereunder.

  • Presentation of Potential Target Businesses The Company shall cause each of the Initial Shareholders to agree that, in order to minimize potential conflicts of interest which may arise from multiple affiliations, the Initial Shareholders will present to the Company for its consideration, prior to presentation to any other person or company, any suitable opportunity to acquire an operating business, until the earlier of the consummation by the Company of a Business Combination or the liquidation of the Company, subject to any pre-existing fiduciary obligations the Initial Shareholders might have.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!